BACKGROUND
although the availability of complete genome sequences and the wealth of large-scale biological data sets opened up unprecedented opportunities to elucidate the genetic basis of rare and common human diseases  <cit> , comprehending the underlying pathophysiological mechanisms continues to be challenging. majority of the common diseases are genetically intricate, polygenic and multifactorial, and frequently manifest as different clinical phenotypes. additionally, these complex conditions are often triggered by an interaction of genetic, environmental, and physiological factors, making it difficult for researchers to narrow their focus to a single or few genes. high-throughput genome-wide studies like linkage analysis and gene expression profiling although useful for classification and characterization do not provide sufficient information to identify specific disease causal genes. both of these approaches typically result in hundreds of potential candidate genes, failing to help the researchers in reducing the target genes to a manageable number for further validation.

functional enrichment approaches  <cit>  focusing on gene sets that share common biological function, chromosomal location, or regulation although successful in identifying enriched biological themes are not suitable for gene prioritization. to overcome this, several gene prioritization methods have been developed  <cit>  . pocus  <cit> , for instance, finds candidate genes by identifying an enrichment of keywords associated with gene ontology , shared protein domains and expression profiles among a given set of susceptibility loci relative to the genome at large. similarly, prospectr  <cit>  and suspects  <cit> , focusing on mendelian and oligogenic disorders, compare go, protein domains and expression libraries of putative disease genes with those known to be involved with the same disease. integrating genomic and proteomic data, mootha et al  <cit>  identified lsfc  causal gene. the recent method, endeavour  <cit> , uses several data sources to prioritize candidate genes. none of these approaches however utilize the mouse phenotype data in their prioritization approaches although mouse is the key model organism for the analysis of mammalian developmental, physiological and disease processes  <cit> . additionally, there have been several reports  <cit>  wherein a direct comparison of human and mouse phenotypes allowed for the rapid recognition of disease causal genes.

extending on the above mentioned approaches, and an earlier hypothesis, that the majority of disease causal genes are functionally closely related  <cit> , we reasoned that an integrative genomics-transcriptomics-phenomics-bibliomics approach utilizing the available human gene annotations, mouse phenotype data and literature co-citations of genes will expedite human complex disease candidate gene identification and prioritization. we call our prioritization method toppgene . for the first time, we incorporated the mouse phenotype data as one of the feature parameters apart from go, pathways, biomedical literature, protein domains, protein interactions and gene expression of genes to prioritize human disease candidate genes and demonstrate its utility.

RESULTS
mouse phenotype as a feature for candidate gene prioritization
the mammalian phenotype  ontology enables robust annotation of mammalian phenotypes in the context of mutations, quantitative trait loci and strains that are used as models of human biology and disease. the mp ontology  supports different levels and richness of phenotypic knowledge and flexible annotations to individual genotypes  <cit> . each node in mpo represents a category of phenotypes and each mp ontology term has a unique identifier, a definition, synonyms, and is associated with gene variants causing these phenotypes in genetically engineered or mutagenesis experiments. in the current study, we retrieved mouse genes associated with each of the mp term and extracted the corresponding human orthologous genes. in the current version of mpo, there are  <dig> terms associated to  <dig> unique entrez mouse genes . we do not check whether the human orthologous gene of a mouse gene causes similar phenotype. rather, we assume that orthologous genes cause "orthologous" phenotype and test the potential of the extrapolated mouse phenotype terms as a similarity measure between the training and test group of genes in candidate gene analysis.

document identifier as a feature for candidate gene prioritization
we use biomedical literature abstract identifiers  as a feature for classification, where the dimensionality of the feature space was equal to the number of documents in the document set. we hypothesized that if a pmid is cross-referenced in two genes, the two genes are likely to have a direct or indirect association. a large number of co-citations for a pair of genes  probably represents a relationship  between the two genes. for each gene, toppgene considers all associated articles  as literature annotation of this gene. the gene to pmid association file  was downloaded from ncbi entrez gene ftp site  <cit> .  <dig> pmids were associated with more than one gene and  <dig> genes had at least one pmid association.  <dig> genes shared at least one pmid with another gene. for the current study, we do not look into the details of the relationship type between the genes but consider only co-citation. in other words, the pmids are used only as a feature of similarity measure in the candidate gene analysis.

comparison of toppgene with other gene prioritization approaches
to evaluate the performance of our approach and also compare it with other similar gene prioritization approaches  <cit> , we performed two types of comparisons: large-scale cross-validations and small-scale test cases . for large-scale cross-validations, we used the same or similar training sets as mentioned in the previous methods. specifically we compared toppgene's performance with endeavour  <cit>  using random-gene cross-validation; and for comparison with prospectr  <cit>  and suspects  <cit> , we used locus-region cross-validation. additionally, as test cases, we selected two diseases, congenital heart defects  and diabetic retinopathy , and compared the prioritization performance of toppgene with suspects  <cit>  and endeavour  <cit> .

gene length
protein interactions
protein interactions
comparison of toppgene with endeavour: random-gene cross-validation
in the current study we used our own disease training sets because the complete data sets used by endeavour are not available for public access. we, therefore, randomly selected  <dig> diseases along with their associated genes from online mendelian inheritance in man  and the genetic association database . each disease gene set contained  <dig> to  <dig> genes. the total number of genes across  <dig> selected diseases was  <dig> . for negative controls,  <dig> sets, each containing  <dig> random genes, were created as training data. we followed the same methodology as endeavour to evaluate the performance of our prioritization method and also compare the results with endeavour. in each validation run, the gene group of a particular disease  was used as the training set. the "target" gene was then mixed with  <dig> random genes to make a test set of  <dig> genes. the rank of the "target" gene in the resulting list, following prioritization, was recorded. this process was repeated for each gene in the list. sensitivity was defined as the frequency of "target" genes that are ranked above a particular threshold position, and specificity as the percentage of genes ranked below the threshold. for instance, a sensitivity/specificity value of 70/ <dig> indicates that the correct disease gene  is ranked among the best-scoring 10% of genes in 70% of the prioritizations. receiver operating characteristic  curves were plotted based on the sensitivity/specificity values and area under curve  was computed as the standard measure of the performance of the method. endeavour reported 90/ <dig> sensitivity/specificity value and an auc score of  <dig>   <cit> .

using toppgene, we first created the overall roc curves. in order to compare with endeavour directly, we followed the same definitions for sensitivity and specificity as described by aerts et al  <cit> . figure  <dig> shows the overall roc curves using toppgene. the auc score of the  <dig> disease training sets was  <dig> , and the sensitivity/specificity was 90/ <dig>  i.e. the "target" gene was ranked among the top 23% in 90% of the cases. in case of the control, the auc score of the  <dig> random training sets was  <dig>  .

second, we studied the roc curves based on p-value based scores. endeavour provides ranking of the "target" gene based on p-values from order statistics, which are local p-values. in contrast, toppgene provides p-values based on random sampling of the whole genome. toppgene p-value based scores are therefore global measures of the similarity of the test genes to the training genes. as a result, sensitivity and specificity can also be defined based on the p-value based scores; specifically, sensitivity is the true positive rate  at a cutoff score, and specificity is the true negative rate  at the same cut-off level. for example, a sensitivity/specificity of 70/ <dig> indicates that 70% of the "target" genes and 10% of the "non-target" genes have scores higher than a particular cut-off value.

evaluation of features used for gene prioritization in toppgene
to study the efficiency of different features , roc curve of each of the feature sets was generated. figure  <dig> shows the corresponding auc scores of the roc curves, depicting the relative performance of each feature set in the prioritization method. the mouse phenotype and pubmed showed the best performance while protein interactions and gene expression features performed poorly. in terms of coverage , pubmed was the best while mp had least coverage .

to understand better the relative performance and the power of each of the features in gene prioritization, we tested toppgene by performing cross-validations with one of the features left out. the performance decreased significantly only when mp was removed . as expected, the best performance was recorded when all the features were considered for prioritization, with an auc of  <dig>   and a coverage of ~89%. for a cutoff score of  <dig> , the sensitivity/specificity was 74/ <dig>  in other words, 74% of the "target" genes were included in the candidate list .

comparison of toppgene with suspects and prospectr: locus-region cross-validation
in this cross-validation we compared the performance of toppgene with two other gene prioritization methods, namely, suspects  <cit>  and prospectr  <cit> . we used the same data set  <cit>  that was used in suspects and prospectr study . this data set contains a list of  <dig> omim diseases . for each cross-validation run, the training set was composed of all the genes related to a disease except the "target" gene. the test set was created by including all the genes in the  <dig> mb locus region i.e. genes occurring in the  <dig>  mb flanking regions  of the "target" gene's chromosomal location along with the "target" gene itself.

prospectr, which uses sequence features alone for gene prioritization, ranked the "target" gene in an average of top  <dig> % in the prioritized test lists and among the top 5% about  <dig> times out of  <dig> . on the other hand, suspects, which uses go, protein domains, gene expression, and sequence features for gene prioritization, ranked the "target" genes in the top 5% of the prioritized lists  <dig> times out of  <dig> , and on average the "target" genes were ranked at top  <dig> % in the prioritization results.

in comparison, toppgene was able to rank the "target" gene among the top 5% of the prioritized lists for  <dig> times out of  <dig> . five genes in the original list were not present in the current ncbi entrez gene database and were therefore excluded. thus, instead of  <dig> genes,  <dig> genes were used for this cross-validation test. on average, the "target" genes were ranked at top  <dig> % in the prioritized lists using our approach .

to evaluate the performance of the individual feature, we repeated the same locus-region cross-validation with one feature removed at a time . the performance did not change significantly if only go, pathway, protein domains, protein interactions or gene expression features were excluded during gene prioritization. the performance however declined significantly when mp or pubmed was not included as one of the features in gene prioritization .

comparison of toppgene with endeavour and suspects
test case 1: congenital heart disease 
we used  <dig> genes implicated in congenital heart disease   as the test case and prioritized the genes using the random-gene cross-validation method as described in the earlier sections. in each run, same training and test sets were submitted to suspects, endeavour and toppgene manually. twenty-eight prioritizations were performed by each of the three methods and the average size of the test sets was  <dig> genes.

following the prioritization, the "target" genes were ranked among the top 5% in the resulting lists  <dig>   <dig>  and  <dig> times out of  <dig> , and in the top 10%  <dig>   <dig> and  <dig> times  with suspects, endeavour and toppgene respectively. the average rank ratios of the "target" genes were  <dig> %,  <dig> % and  <dig> % for suspects, endeavour and our approach respectively .

test case 2: diabetic retinopathy 
a similar comparative analysis was repeated with diabetic retinopathy  as a test case using locus-region cross-validation as described in previous section. the training set comprised  <dig> known genes implicated in dr  while the test sets comprised genes in the locus regions of the "target" genes.

the "target" genes were ranked among top 5% in the resulting lists  <dig> times out of  <dig>  with both suspects and endeavour based gene prioritization. as witnessed in earlier comparisons, toppgene again outperformed both suspects and endeavour by ranking the "target" genes among top 5% in  <dig> times out of  <dig> . if we considered the top 10%, surprisingly suspects fared better than endeavour and was close to toppgene's performance. thus, the "target" genes were ranked among the top 10% of the prioritized gene lists  <dig>   <dig> and  <dig> times  respectively with suspects, endeavour and toppgene. the average rank ratios of the "target" genes were  <dig> %,  <dig> % and  <dig> % for suspects, endeavour and our approach respectively .

toppgene implementation and access
the programs of our prioritization method are implemented purely in java. open source java package ftpbean by calvin tai  <cit>  is used to automatically download data and annotation files from ftp servers. biojava packages  <cit>  are used to process uniprot records  <cit>  and extract related protein domain information. golem  <cit>  source code was adapted and modified for dealing with ontology annotations. colt  <cit>  and jakarta commons-math libraries  <cit>  are used for statistical analysis. the fuzzy similarity measure and related functions are implemented locally.

our prioritization method is available as a standalone web application  <cit> . the user interface is written in java script, jsp and servlets, and integrated with the tomcat web server. users can enter the training and test sets of genes of interest as queries from the interface, and the application will display enriched themes  in the training set genes along with annotated prioritized test genes. all the gene information and annotation data will be updated automatically except for pathways.

discussion
traditionally there are two categories of approaches to compute the similarity between any two genes based on semantic annotations: pair-based and set-based  <cit> . in pair-based methods, an average or maximum of pairwise term information content is calculated as the similarity between the two genes. this will however cause inconsistency problems. specifically, an average of pairwise term information content tends to underestimate the similarities  while a maximum of pairwise term information content tends to overestimate the similarity . on the other hand, set-based similarity measures, such as jaccard and dice similarity  <cit> , will generate  <dig> if the two genes do not share a common annotation term. this behavior is especially undesirable for annotation terms from ontologies. the fuzzy-based similarity measure adopted and applied in our approach can overcome these problems and therefore could generate a better similarity measure than the traditional methods.

most of the current tools to enrich lists of genes or candidate gene prioritization are based on go, gene expression or pathways  <cit> . previous studies have also shown that integrating multiple lines of evidence is good for candidate gene analysis. however, to the best of our knowledge none of the previous candidate gene prioritization approaches used mouse phenotype features although the mouse is a key model organism for the analysis of mammalian developmental, physiological, and disease processes  <cit> . additionally, there have been reports wherein a direct comparison of human and mouse phenotypes allowed for the rapid recognition of disease causal genes . in this paper, for the first time, we use phenotype annotations for mouse orthologs of human genes as one line of evidence for candidate gene analysis. we are aware that comparing phenotypes between two different organisms may involve consideration of several issues. for instance, the mouse genotype may involve mutations to orthologs of one or more of the genes associated with a phenotype, but the mouse phenotype may not resemble the disease in human. nevertheless, finding, for instance that targeted disruption of the mouse ortholog of human cfc <dig> gene  results in l-r laterality defects including cardiac malformations  <cit>  can lead to novel and interesting hypotheses. although, our results have conclusively demonstrated the utility of mouse phenotype data in human candidate gene analysis, there are some inherent limitations in using mouse phenotype annotations. for instance, mp is not a disease-centric ontology and the phenotype of a same gene mutation can vary depending on specific mouse strains or their genetic backgrounds. most importantly, orthologous genes need not necessarily result in orthologous phenotypes. we are currently working on a more efficient cross-species phenome extrapolation where in the mouse phenotype terms are mapped to human phenotype concepts  semantically  and the resultant orthologous genes associated with an orthologous phenotype are identified. how to efficiently utilize this kind of information in human disease candidate gene prioritization is a topic of future research.

apart from the contribution of mp, improved performance of toppgene over other methods can be attributed partially to the usage of more comprehensive data resources. for instance, unlike endeavour, the pathway data set in toppgene is not limited to kegg resource. we compiled more than  <dig> additional pathways  from various sources  and used for gene prioritization.

our approach however has some limitations. first, by using a training set we assume that the disease genes we have yet to discover will be consistent with what is already known about a disease and/or its genetic basis which may not always be the case. second, it is important to note that the annotations and analyses provided and the prioritization by our approach can only be as accurate as the underlying online sources from which the annotations are retrieved. only one-fifth of the known human genes have pathway or phenotype annotations and there are still more than 40% genes whose functions are not defined . third, using an appropriate training set â€“ although the difference was not significant, while cross-validating, we noted that using larger training sets  would decrease the sensitivity and specificity of the prioritization when compared to using smaller training sets .

CONCLUSIONS
existing disease candidate gene prioritization methodologies mine biological and functional information about candidate genes, and we believe that our system, toppgene, can complement these existing approaches by using a novel method that mines mouse phenotype data. the aim of toppgene is to generate likely candidates by extensive analysis of all known characteristics of genes, and is inevitably restricted by existing information be it go annotation, pathways, phenotype or gene expression data. through various examples, we demonstrate that toppgene performs better than suspects, prosepctr and endeavour in candidate gene prioritization. however, it needs to be emphasized that our aim is not to prove that toppgene prioritized genes are true disease genes but to aid in selection of a subset of most likely disease gene candidates from larger sets of disease-implicated genes identified by high throughput genome-wide techniques like linkage analysis and microarray analysis. for the first time, we have used the mouse phenotype data in human disease candidate gene analysis. our results demonstrate that employing the mouse phenotype data improves candidate gene prioritization significantly and can therefore aid in the process of focusing the search for the most likely human disease gene candidates. lastly, as the functional annotations of human and mouse genes improve, especially the mouse phenotype annotations, we envisage a proportional increase in the performance of toppgene and strongly believe that it will be a valuable adjunct to wet lab experiments in human genetics and disease research.

